Associate Professor Kara Britt leads the Breast Cancer Risk and Prevention Lab within the Cancer Evolution and Metastasis Program.

Kara obtained her PhD from Monash University working on female reproductive endocrinology. She undertook a CJ Martin fellowship at the Institute of Cancer Research (UK) under the mentorship of Alan Ashworth and Matthew Smalley where she began working on breast cancer.

Kara’s work has helped define why women in today’s society have an increased incidence of breast cancer. Her lab has been instrumental in developing pre-clinical models for prevention based research.

She has held Early and Mid-Career Victorian Cancer Agency Fellowships and a National Breast Cancer Foundation (NBCF) Early Career fellowship. Her work has been supported by NHMRC, Equity Trustees, NBCF, and the Basser Centre (USA).

Kara also co-chairs the VCCC Accelerating Novel Therapies Program which aims to increase the number of new drugs translating through to the patients that need it most.